[Results of glucose tolerance tests and changes in inorganic serum phosphate and potassium levels in schizophrenic patients responding to treatment with psychotropic drugs].
D000293:Adolescent; D000328:Adult; D000639:Amitriptyline / Q000627:therapeutic use; D002746:Chlorpromazine / Q000627:therapeutic use; D003975:Diazepam / Q000627:therapeutic use; D005951:Glucose Tolerance Test; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D008297:Male; D008728:Methotrimeprazine / Q000627:therapeutic use; D008875:Middle Aged; D010640:Phenothiazines / Q000627:therapeutic use; D010710:Phosphates / Q000097:blood*; D010783:Photometry; D011188:Potassium / Q000097:blood*; D012559:Schizophrenia / Q000188:drug therapy / Q000378:metabolism*; D013997:Time Factors; D014268:Trifluoperazine / Q000627:therapeutic use; D014272:Trifluperidol / Q000627:therapeutic use
D010640:Phenothiazines; D010710:Phosphates; D000639:Amitriptyline; D014268:Trifluoperazine; D008728:Methotrimeprazine; D006220:Haloperidol; D007099:Imipramine; D003975:Diazepam; D014272:Trifluperidol; D011188:Potassium; D002746:Chlorpromazine
Das Verhalten der Glucosebelastungskurve sowie der Konzentrationsveränderungen des anorganischen Serumphosphorund -kalimspiegels bei den auf die Psychopharmakonbehandlung reagierenden und nicht reagierenden Schizophrenen.